. 2022 Mar 29;7(2):I–XIX. doi: 10.1177/23969873221078696
© European Stroke Organisation 2022
This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Prisma flow diagram on Hormone replacement therapy (HRT) and Stroke Risk.